| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Motilal Oswal Nifty MidSmall Healthcare Index Fund (G) Direct |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-1.83 |
| Equity |
99.68 |
| Trep |
2.15 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
40.86% |
| Top 10 Holdings |
60.50% |
| Top 25 Holdings |
93.67% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
62.03 |
| Healthcare |
37.65 |
| Cash |
0.32 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
5.61 |
| PE Ratio |
42.44 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Max Healthcare Institute Limited |
15.01 |
| Lupin Limited |
8.49 |
| Fortis Health Care Ltd |
6.60 |
| Aurobindo Pharma Limited |
5.76 |
| Mankind Pharma Limited |
5.00 |
| Alkem Laboratories Limited |
4.86 |
| Laurus Labs Limited |
4.28 |
| Glenmark Pharmaceuticals Limited |
3.94 |
| IPCA Laboratories Limited |
3.55 |
| Krishna Inst of Medical Sciences Ltd. |
3.01 |
| Abbott India Limited |
2.86 |
| Biocon Limited |
2.71 |
| Glaxosmithkline Pharma Ltd |
2.45 |
| Cohance Lifesciences Limited |
2.40 |
| Piramal Pharma Limited |
2.28 |
| Gland Pharma Limited |
2.27 |
| Aster DM Healthcare Limited |
2.26 |
| Syngene International Limited |
2.19 |
| J B Chemicals and Pharma Ltd |
2.16 |
| Collateralized Borrowing & Lending Obligation |
2.15 |
| Narayana Hrudalaya Ltd |
2.13 |
| Ajanta Pharma Limited |
1.90 |
| Dr Lal Path Labs Ltd |
1.86 |
| EQ- GLOBAL HEALTH LTD. |
1.78 |
| Neuland Laboratories Limited |
1.77 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
